Nasopharyngeal neoplasm
MONDO:0005375A benign or malignant neoplasm affecting the nasopharynx. Representative examples of benign neoplasms include angiofibroma and squamous papilloma. Representative examples of malignant neoplasms include keratinizing squamous cell carcinoma and nonkeratinizing carcinoma.
Also known as: nasopharyngeal neoplasms, nasopharyngeal tumor, nasopharyngeal tumour, nasopharynx neoplasm, nasopharynx neoplasm (disease), nasopharynx tumor, nasopharynx tumour, neoplasm of nasopharynx
1665 clinical trials for this condition and its sub-types, 37 tagged with Nasopharyngeal neoplasm itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Nasopharyngeal neoplasm
-
Malignant tumor of nasopharynx 9 trials · 213 incl. sub-types
1 sub-type
- Nasopharyngeal carcinoma 210 trials · 211 incl. sub-types Sub-types →
-
Benign neoplasm of nasopharynx 0 trials
-
Nasopharyngeal teratoma 0 trials
Most studied deeper sub-types
-
Experimental cancer drug TAK-500 tested in 61 patients – study halted early
Disease control Stopped earlyThis early-phase trial tested an experimental drug called TAK-500, alone or with the immunotherapy pembrolizumab, in 61 adults with advanced solid tumors like pancreatic, liver, and lung cancer. The main goals were to check safety and see if the drug could shrink tumors. The stud…
Phase 1/2 • Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Experimental cancer drug INCB062079 tested in early trial
Disease control Stopped earlyThis early-phase trial tested a new drug called INCB062079 in 25 people with advanced liver cancer and other solid tumors. The main goal was to check safety and find the best dose. The study was terminated early, so results are limited.
Phase 1 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC